Switzerland
Medizinprodukt-Marktintelligenz für Switzerland. Regulatorische Änderungen, Wettbewerber und Beschaffungstrends.
Länder-Tabelle zuletzt: 9. Aug. 2026 (kann veraltet sein). 7-Tage-Zahl ist live neu berechnet. Tabellenwert war 48.
Signale der letzten 7 Tage
Expanding Diagnostics: Fast, Portable Tests Could Transform the Fight Against TB
Sustainable Transition: Advancing a Managed Path to Domestic Financing in Indonesia
Regional Impact: Cross-border Coordination Drives Down Malaria Cases in Southern Africa
Prevention Breakthrough: A Historic HIV Innovation Delivered at Unprecedented Speed
Resilient Laboratories: Strengthening Disease Detection Despite Years of War in Ukraine
Global Fund Report Shows Countries Fought to Protect Essential Health Services Despite Challenging Year
Despite Funding Cuts, Global Fund Sustains Progress Against HIV, TB and Malaria
Summary report on authorisation – Serum autolog Universitätsspital Basel, eye drops® - Swissmedic
swissdamed Webinar 10 November 2026 - Swissmedic
Symptoms, transmission, and current treatments for sleeping sickness - Drugs for Neglected Diseases initiative (DNDi)
Summary report on authorisation – Abrysvo® - Swissmedic
When Harm Hides in Hospital: Messaging and the Medicalisation of Female Genital Mutilation
Yemen: Renewed fighting puts pressure on the health system
Summary report on authorisation – Ogsiveo® - Swissmedic
Summary report on authorisation – Tranylcypromine Rivopharm® - Swissmedic
A serological method’s ability to distinguish treatment regimens by assessing early antibody decline in Chagas patients: insights from E1224 data - Drugs for Neglected Diseases initiative (DNDi)
Developing Countries Unite Over Need for Binding Contracts with Pharma at Pandemic Talks
Hepatitis C virus, flaviviruses and related viruses (HCV-Flavi) 2026 - Drugs for Neglected Diseases initiative (DNDi)
DRC’s Ebola Lessons: Learned and Unlearned (Part I)
Summary report on authorisation – Sérum autologue ICH, eye drops® - Swissmedic